Crossref journal-article
Ovid Technologies (Wolters Kluwer Health)
Stroke (276)
Abstract

Background and Purpose A process resembling programmed cell death appears to contribute to postischemic neuronal loss in several models of stroke. Because the expression of the bcl-2 gene has been shown to rescue neurons from programmed cell death due to other causes, we determined whether it would be similarly neuroprotective in stroke. Methods Replication defective herpes viral vectors that transduce bcl-2 (HSVbcl2) or Escherichia coli lacZ (HSVlac) were injected into two sites in the rat cerebral cortex 24 hours before induction of neocortical focal ischemia by tandem permanent occlusion of the right middle cerebral artery and ipsilateral common carotid artery. Local ischemic damage was determined 24 hours after occlusion by staining with 2% 2,3,5-triphenyltetrazolium chloride. Results Expression of bcl-2 in cerebral cortex was confirmed by immunohistochemistry in animals injected with the HSVbcl2 expression vector. Viable tissue was significantly increased at the injection sites in HSVbcl2- but not HSVlac-injected animals. The protection observed in the HSVbcl2 animals was localized to the injection sites. Conclusions These data indicate that bcl-2 expression protects neurons in vivo from ischemic injury and suggest the feasibility of gene therapy for stroke and perhaps other neurological diseases in which programmed cell death is involved.

Bibliography

Linnik, M. D., Zahos, P., Geschwind, M. D., & Federoff, H. J. (1995). Expression of bcl-2 From a Defective Herpes Simplex Virus–1 Vector Limits Neuronal Death in Focal Cerebral Ischemia. Stroke, 26(9), 1670–1675.

Authors 4
  1. Matthew D. Linnik (first)
  2. Peter Zahos (additional)
  3. Michael D. Geschwind (additional)
  4. Howard J. Federoff (additional)
References 50 Referenced 234
  1. 10.1146/annurev.ne.13.030190.001131
  2. 10.1016/0891-5849(89)90057-9
  3. 10.1016/0006-8993(90)90144-Z
  4. 10.1161/str.24.12.8248983
  5. 10.1161/str.25.4.8160232
  6. 10.1111/j.1471-4159.1993.tb09843.x
  7. 10.1016/0304-3940(93)90864-H
  8. 10.1097/00001756-199401120-00031
  9. 10.1038/jcbfm.1994.119
  10. 10.1146/annurev.cb.07.110191.003311
  11. 10.1146/annurev.ne.14.030191.002321
  12. 10.1146/annurev.ne.16.030193.000335
  13. 10.1126/science.8235659
  14. 10.1016/0169-328X(93)90139-G
  15. 10.1006/bbrc.1993.2571
  16. 10.1016/0092-8674(93)90230-N
  17. 10.1016/0896-6273(94)90266-6
  18. 10.1016/0896-6273(90)90171-B
  19. 10.1073/pnas.89.5.1636
  20. 10.1089/hum.1992.3.5-487
  21. 10.1016/0014-4886(92)90196-W
  22. 10.1089/hum.1992.3.1-11
  23. Breakefield X Huang Q Andersen J Kramer M Bebrin W Davar G Vos B Garber D Difiglia M Coen D. Gene transfer into the nervous system using recombinant herpes virus vectors. In: Gage F Christen Y eds. Gene Transfer and Therapy in the Nervous System. Heidelberg FRG: Springer-Verlag; 1992:45-48. (10.1007/978-3-642-84842-1_10)
  24. 10.1128/MCB.8.1.457
  25. 10.1016/1044-7431(91)90062-S
  26. 10.1073/pnas.90.8.3655
  27. 10.1126/science.266.5189.1399
  28. 10.1126/science.2843986
  29. 10.1016/0169-328X(94)90146-5
  30. 10.1006/dbio.1994.1131
  31. 10.1523/JNEUROSCI.13-03-00941.1993
  32. 10.1073/pnas.90.13.6165
  33. Geschwind M Lu B Federoff H. Viral transfection of intrinsic cells within the brain: expression of neurotrophic genes from HSV-1 vectors: modifying neuronal phenotype. In: Conn PM ed. Providing Pharmacological Access to the Brain. Orlando Fl: Academic Press Inc; 1994:462-482. (10.1016/B978-0-12-185291-7.50033-3)
  34. Federoff H. Growth of replication defective herpes virus amplicon vectors and their use for gene transfer. In: Spector D Goldman R Lienwand L eds. Cell Biology: A Laboratory Manual. Cold Spring Harbor NY: Cold Spring Harbor Press; 1995.
  35. Johnson P, Miyanohara A, Levine F, Cahill T, Friedman T. Cytotoxicity of replication-defective mutant of herpes simplex virus type 1. J Virol. 1992;66:2952-2965. (10.1128/jvi.66.5.2952-2965.1992) / J Virol (1992)
  36. 10.1099/0022-1317-71-8-1775
  37. Paxinos GT Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. New York NY: Academic Press; 1986.
  38. 10.1111/j.1365-2990.1988.tb00889.x
  39. 10.1038/jcbfm.1988.88
  40. 10.1161/01.STR.17.4.738
  41. Casals-Hatem D, Louie D, Tanaka S, Reed J. Molecular cloning and DNA sequence analysis of cDNA encoding chicken homolog of the bcl-2 oncoprotein. Biochem Biophys Acta. 1992;1132:109-113. / Biochem Biophys Acta (1992)
  42. 10.1128/MCB.9.2.701
  43. 10.1038/348334a0
  44. 10.1073/pnas.89.16.7295
  45. 10.1038/361365a0
  46. 10.1016/S0021-9258(18)82073-7
  47. 10.1016/0092-8674(93)80066-N
  48. 10.1073/pnas.90.10.4533
  49. 10.1038/371336a0
  50. 10.1016/0304-3940(95)11310-S
Dates
Type When
Created 14 years, 2 months ago (June 17, 2011, 4:08 p.m.)
Deposited 1 year, 3 months ago (May 12, 2024, 6:02 p.m.)
Indexed 3 months ago (May 27, 2025, 2:03 a.m.)
Issued 29 years, 11 months ago (Sept. 1, 1995)
Published 29 years, 11 months ago (Sept. 1, 1995)
Published Print 29 years, 11 months ago (Sept. 1, 1995)
Funders 0

None

@article{Linnik_1995, title={Expression of bcl-2 From a Defective Herpes Simplex Virus–1 Vector Limits Neuronal Death in Focal Cerebral Ischemia}, volume={26}, ISSN={1524-4628}, url={http://dx.doi.org/10.1161/01.str.26.9.1670}, DOI={10.1161/01.str.26.9.1670}, number={9}, journal={Stroke}, publisher={Ovid Technologies (Wolters Kluwer Health)}, author={Linnik, Matthew D. and Zahos, Peter and Geschwind, Michael D. and Federoff, Howard J.}, year={1995}, month=sep, pages={1670–1675} }